nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Homozygous NDUFS6 Variant Associated with Neuropathy and Optic Atrophy
|
Gangfuß, Andrea |
|
|
11 |
2 |
p. 485-491 |
artikel |
2 |
Antisense Oligonucleotide-Mediated Downregulation of IGFBPs Enhances IGF-1 Signaling
|
Yavas, Alper |
|
|
11 |
2 |
p. 299-314 |
artikel |
3 |
Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation
|
Lu, Qi L. |
|
|
11 |
2 |
p. 275-284 |
artikel |
4 |
Burden of Disease of Duchenne Muscular Dystrophy in Denmark – A National Register-Based Study of Individuals with Duchenne Muscular Dystrophy and their Closest Relatives
|
Rudolfsen, Jan Håkon |
|
|
11 |
2 |
p. 443-457 |
artikel |
5 |
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study
|
Ricci, Giulia |
|
|
11 |
2 |
p. 375-387 |
artikel |
6 |
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease
|
McDonald, Craig |
|
|
11 |
2 |
p. 499-523 |
artikel |
7 |
DySMA – an Instrument to Monitor Swallowing Function in Children with Spinal Muscular Atrophy ages 0 to 24 Months: Development, Consensus, and Pilot Testing
|
Zang, Jana |
|
|
11 |
2 |
p. 473-483 |
artikel |
8 |
Expert Insights from a Delphi-driven Neurologists’ Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy
|
Lidonnici, Dario |
|
|
11 |
2 |
p. 411-423 |
artikel |
9 |
Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation
|
McNiff, Megan M. |
|
|
11 |
2 |
p. 459-472 |
artikel |
10 |
IL-6 and TNF are Potential Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy
|
Greco, Anna |
|
|
11 |
2 |
p. 327-347 |
artikel |
11 |
Living with Dysphagia: A Survey Exploring the Experiences of Adults Living with Neuromuscular Disease and their Caregivers in the United Kingdom
|
Allen, Jodi |
|
|
11 |
2 |
p. 389-410 |
artikel |
12 |
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa
|
Boentert, Matthias |
|
|
11 |
2 |
p. 369-374 |
artikel |
13 |
Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry
|
Servais, Laurent |
|
|
11 |
2 |
p. 425-442 |
artikel |
14 |
Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies – A Case Report
|
Eisenkölbl, Astrid |
|
|
11 |
2 |
p. 493-498 |
artikel |
15 |
Risdiplam in Spinal Muscular Atrophy: Safety Profile and Use Through The Early Access to Medicine Scheme for the Paediatric Cohort in Great Britain
|
Cornell, Nikki |
|
|
11 |
2 |
p. 361-368 |
artikel |
16 |
SERCA1 Overexpression in Skeletal Muscle Attenuates Muscle Atrophy and Improves Motor Function in a Mouse Model of ALS
|
Mázala, Davi A.G. |
|
|
11 |
2 |
p. 315-326 |
artikel |
17 |
The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report
|
Armstrong, Niki |
|
|
11 |
2 |
p. 525-533 |
artikel |
18 |
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy
|
Bello, Luca |
|
|
11 |
2 |
p. 285-297 |
artikel |
19 |
The Importance of Early Treatment of Inherited Neuromuscular Conditions
|
Mackels, Laurane |
|
|
11 |
2 |
p. 253-274 |
artikel |
20 |
Treatment of Symptomatic Spinal Muscular Atrophy with Nusinersen: A Prospective Longitudinal Study on Scoliosis Progression
|
Ip, Hoi Ning Hayley |
|
|
11 |
2 |
p. 349-359 |
artikel |